Connect with us

Technology

Precision Optics Reports Second Quarter Fiscal Year 2024 Financial Results

Published

3 years ago

on

Conference Call Scheduled for today, February 14, 2024, at 5:00pm ET.

GARDNER, Mass., Feb. 14, 2024 /PRNewswire/ — Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, announced operating results on an unaudited basis for its second quarter fiscal year 2024 for the period ended December 31, 2023.

Q2 2024 Financial Highlights (3 Months Ended December 31, 2023):

Revenue decreased 18% to $4.8 million, compared to $5.9 million in the same quarter of the previous fiscal year, but up 12% from the most recent sequential quarter. The year ago second quarter included a one-time sale of $600,000 of technology rights relating to a single-use medical device developed for a customer.Engineering revenue increased 33% to $2.3 million compared to $1.7 million in the same quarter of the previous fiscal year, and up 19% from the most recent sequential quarter.Production revenue was $2.6 million compared to $3.6 million in the same quarter of the previous fiscal year, and $2.4 million in the most recent sequential quarter.Gross margins were 30.1% compared to 44.2% in the same quarter of the previous year. Removing the impact of the technology rights revenue, gross margins a year ago would have been 37.8%.Net loss for the quarter was ($758,802), compared to a net income of $508,668 in the same quarter of the previous year. Adjusted EBITDA was ($269,034) for the quarter compared to $866,450 in the same quarter of the previous year. 

Recent Additional Highlights:

In November 2023, the Company announced the receipt of initial purchase orders towards a $1.4 million total program development project to develop a highly complex imaging sub-assembly for a next generation ophthalmoscope for one of the world’s largest technology-focused medical device companies.In December 2023, the Company announced the signing of a production and technology license agreement with a leading surgical robotics company to supply a single-use endoscope assembly used in their cystoscopy robotic surgery system.

Precision Optics’ CEO, Joseph Forkey, commented, “The Company’s results for Q2 were generally in-line with our expectations and consistent with what we have communicated previously.  While revenue was lower compared to last year due to timing differences between reorders for ongoing production, the exit of certain mature customer programs and the introduction of new customer programs, we have begun to see the rebound we expected with two new programs moving to production in the quarter and another restarting after a pandemic-related hold.  These programs contributed to a 6% quarter-over-quarter increase in production revenue, which, combined with record engineering revenue led to a 12% increase in total revenue compared to the first quarter.  Margins for the second quarter were lower than the first quarter, due to a differing sales mix, lower than normal production yields on certain programs starting or re-starting production as well as other one-time charges.  We believe these margin issues are transient and will be substantially resolved in the second half of the year, with gross margins returning to historical levels.

Dr. Forkey continued, “The growth we expect in the second half of fiscal 2024 is supported by the strength of our engineering pipeline, a leading indicator of future production volumes.  Engineering revenue was $2.3 million during the second quarter – a new quarterly record, up 33% year-over-year, and up 19% sequentially. We anticipate volumes from production orders coming on-line to lift our overall revenue to new quarterly record run-rates in this fiscal year.  Precision Optics’ core competencies — micro-optics, digital imaging, 3D endoscopy, and single-use medical devices — uniquely position us at the center of market segments that are significantly outpacing the growth of the broader medical device and defense / aerospace industries, providing us with an ongoing opportunity to significantly grow into the future. I look forward to an exciting second half of fiscal 2024.”

The following table summarizes the second quarter and fiscal year to date (unaudited) results for the periods ended December 31, 2023, and 2022:

Three Months

Six Months

Ended December 31,

Ended December 31,

2023

2022

2023

2022

Revenues

$4,824,289

$5,886,961

$9,145,544

$10,972,262

Gross Profit

1,450,976

2,599,472

2,914,587

4,238,913

Stock Compensation Expenses

382,431

108,746

491,177

319,776

Other

1,772,707

1,919,661

3,532,865

3,449,874

Total Operating Expenses

2,155,138

2,028,407

4,024,042

3,769,650

Operating Income (Loss)

(704,162)

571,065

(1,109,455)

469,263

Net Income (Loss)

(758,802)

(508,668)

(1,223,217)

349,944

Income (Loss) per Share

Basic

$          (0.13)

$          (0.09)

$          (0.20)

$               0.06

Fully Diluted

$          (0.13)

$          (0.09)

$          (0.20)

$               0.06

Weighted Average Common Shares Outstanding

Basic

6,066,572

5,638,302

6,066,545

5,638,302

Fully Diluted

6,066,572

5,935,911

6,066,545

5,937,471

Note: The Common Shares in this table reflect shares on a post reverse split basis for all periods presented.

Conference Call Details
Date and Time: Wednesday, February 14, 2024, at 5:00pm ET

Call-in Information: Interested parties can access the conference call by dialing (844) 735-3662 or
(412) 317-5705.

Live Webcast Information: Interested parties can access the conference call via a live webcast, which is available at https://app.webinar.net/5l19x2DzRKG.

Replay: A teleconference replay of the call will be available until February 21, 2024, at (877) 344-7529 or (412) 317-0088, replay access code 9304851. A webcast replay will be available at https://app.webinar.net/5l19x2DzRKG.  

About Precision Optics Corporation
Founded in 1982, Precision Optics is a vertically integrated optics company primarily focused on leveraging its proprietary micro-optics and  imaging technologies to the healthcare and defense/aerospace industries by providing services ranging from new product concept through mass manufacture.  Utilizing its leading-edge in-house design, prototype, regulatory and fabrication capabilities as well as its Lighthouse Imaging division’s electronic imaging expertise and its Ross Optical division’s high volume world-wide sourcing, inspecting and production resources, the Company designs and manufactures next-generation product solutions to meet the most challenging customer requirements. Within healthcare, Precision Optics enables next generation medical device companies around the world to meet the increasing demands of the surgical community who require more enhanced and smaller imaging systems for minimally invasive surgery, including single-use medical devices, as well as 3D endoscopy systems to support the rapid proliferation of surgical robotic systems. In addition to these next generation applications, Precision Optics has supplied top tier medical device companies with a wide variety of optical products for decades, including complex endocouplers and specialized endoscopes. The Company is also leveraging its technical proficiency in micro-optics to enable leading edge defense/aerospace applications which require the highest quality standards and the optimization of size, weight and power. For more information, please visit www.poci.com.

Non-GAAP Financial Measures
Precision Optics has provided in this press release financial information that has not been prepared in accordance with accounting principles generally accepted in the Unites States of America (“non-GAAP”). The non-GAAP financial measure is Adjusted EBITDA (earnings before interest, taxes, depreciation and amortization). Adjusted EBITDA also excludes from Net Income (Loss) the effect of stock-based compensation, restructuring and other acquisition-related items.

This non-GAAP financial measure assists Precision Optics management in comparing its operating performance over time because certain items may obscure the underlying business trends and make comparisons of long-term performance difficult, as they are of a nature and/or size that occur with inconsistent frequency or relate to discrete acquisition or restructuring plans that are fundamentally different from the ongoing productivity of the Company. Precision Optics management also believes that presenting this measure allows investors to view its performance using the same measures that the Company uses in evaluating its financial and business performance and trends.

Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information calculated in accordance with GAAP. Investors are encouraged to review the reconciliation of non-GAAP measures to their most directly comparable GAAP financial measures. A reconciliation of the non-GAAP financial measure presented above to GAAP results has been provided in the financial tables included with this press release.

About Forward-Looking Statements
This press release contains forward-looking statements. Forward-looking statements include, but are not limited to, statements that express the Company’s intentions, beliefs, expectations, strategies, predictions or any other statements related to the Company’s future activities or future events or conditions. These statements are based on current expectations, estimates and projections about the Company’s business based, in part, on assumptions made by the Company’s management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in the forward-looking statements due to numerous risk factors. Any forward-looking statements speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement, except as required by law.

Company Contact:
PRECISION OPTICS CORPORATION
22 East Broadway
Gardner, Massachusetts 01440-3338
Telephone: 978-630-1800

Investor Contact:
LYTHAM PARTNERS, LLC
Robert Blum
Telephone: 602-889-9700
poci@lythampartners.com

PRECISION OPTICS CORPORATION, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

December 31,

June 30,

2023

2023

ASSETS

Current Assets:

Cash and cash equivalents

$

987,044

$

2,925,852

Accounts receivable, net of allowance for doubtful accounts of $731,256
     at December 31, 2023 and $606,715 at June 30, 2023

3,511,544

3,907,407

Inventories

3,099,986

2,776,216

Prepaid expenses

234,121

249,681

Total current assets

7,832,695

9,859,156

Fixed Assets:

Machinery and equipment

3,253,746

3,227,481

Leasehold improvements

832,305

825,752

Furniture and fixtures

362,287

242,865

Total fixed assets

4,448,338

4,296,098

Less—Accumulated depreciation and amortization

3,966,839

3,862,578

Net fixed assets

481,499

433,520

Operating lease right-to-use asset

275,329

358,437

Patents, net

283,643

265,111

Goodwill

8,824,210

8,824,210

TOTAL ASSETS

$

17,697,376

$

19,740,434

LIABILITIES AND STOCKHOLDERS’ EQUITY

Current Liabilities:

Current portion of capital lease obligation

$

44,519

$

43,209

Current maturities of long-term debt

513,259

513,259

Accounts payable

1,675,742

2,432,264

Customer advances

1,158,242

1,174,690

Accrued compensation and other

747,793

927,521

Operating lease liability

173,503

168,677

Total current liabilities

4,313,058

5,259,620

Capital lease obligation, net of current portion

45,890

68,482

Long-term debt, net of current maturities and debt issuance costs

1,919,350

2,175,980

Operating lease liability, net of current portion

101,826

189,760

Stockholders’ Equity:

Common stock, $0.01 par value: 50,000,000 shares authorized; issued and
     outstanding – 6,067,518 shares at December 31, 2023 and 6,066,518 at June 30, 2023

60,675

60,665

Additional paid-in capital

60,718,801

60,224,934

Accumulated deficit

(49,462,224)

(48,239,007)

Total stockholders’ equity

11,317,252

12,046,592

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

$

17,697,376

$

19,740,434

 

PRECISION OPTICS CORPORATION, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

FOR THE SIX MONTHS ENDED

DECEMBER 31, 2023 AND 2022

(UNAUDITED)

Three Months
Ended December 31,

Six Months
Ended December 31,

2023

2022

2023

2022

Revenues

$

4,824,289

$

5,886,961

$

9,145,544

$

10,972,262

Cost of Goods Sold

3,373,313

3,287,489

6,230,957

6,733,349

Gross Profit

1,450,976

2,599,472

2,914,587

4,238,913

Research and Development Expenses

221,728

155,264

434,486

365,891

Selling, General and Administrative
Expenses

1,933,410

1,873,143

3,589,556

3,403,759

–

Total Operating Expenses

2,155,138

2,028,407

4,024,042

3,769,650

Operating Income (Loss)

(704,162)

571,065

(1,109,455)

469,263

Interest Expense

(54,640)

(62,397)

(113,762)

(119,319)

Net Income (Loss)

$

(758,802)

$

508,668

$

(1,223,217)

$

349,944

Loss Per Share:

Basic

(0.13)

$

0.09

(0.20)

$

0.06

Fully Diluted

$

(0.13)

$

0.09

$

(0.20)

$

0.06

Weighted Average Common Shares
Outstanding:

Basic

6,066,572

5,638,302

6,066,545

5,638,302

Fully Diluted

6,066,572

5,935,911

6,066,545

5,937,471

 

PRECISION OPTICS CORPORATION, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE SIX MONTHS ENDED

DECEMBER 31, 2023 AND 2022

(UNAUDITED)

Six Months
Ended December 31,

2023

2022

Cash Flows from Operating Activities:

Net Income (Loss)

$

(1,223,217)

$

349,944

Adjustments to reconcile net loss to net cash used in by operating activities –

Depreciation and amortization

104,261

104,750

Stock-based compensation expense

491,177

319,776

Non-cash interest expense

8,752

16,966

Changes in operating assets and liabilities –

Accounts receivable, net

395,863

(1,368,650)

Inventories, net

(323,770)

232,963

Prepaid expenses

15,560

271

Accounts payable

(756,522)

216,060

Customer advances

(16,448)

(110,132)

Accrued compensation and other

(188,480)

255,162

Net cash (used in) provided by operating activities

(1,492,824)

17,110

Cash Flows from Investing Activities:

Purchases of fixed assets

(152,240)

(13,583)

Additional patent costs

(18,532)

(24,054)

Net cash used in investing activities

(170,772)

(37,637)

Cash Flows from Financing Activities:

Payments of capital lease obligations

(21,282)

(20,049)

Payments of long-term debt

(256,630)

(183,855)

Gross proceeds from the exercise of stock options

2,700

–

Net cash used in financing activities

(275,212)

(203,904)

–

Net (decrease) increase in cash and cash equivalents

(1,938,808)

(224,431)

Cash and cash equivalents, beginning of period

2,925,852

605,749

Cash and cash equivalents, end of period

$

987,044

$

381,318

 

PRECISION OPTICS CORPORATION, INC. AND SUBSIDIARIES

RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES

ADJUSTED EBITDA

Three Months

Six Months

Ended December 31,

Ended December 31,

2023

2022

2023

2022

Net Income (loss) (GAAP)

$

(758,802)

$

508,668

$

(1,223,217.00)

$

349,944

Stock based compensation

382,431

244,786

491,177.00

319,776

Depreciation and Amortization

52,697

52,667

104,261.00

105,078

Interest expense

54,640

60,329

113,762.00

117,251

Adjusted EBITDA (non-GAAP)

$

(269,034)

$

866,450

$

(514,017)

$

892,049

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/precision-optics-reports-second-quarter-fiscal-year-2024-financial-results-302062206.html

SOURCE Precision Optics Corporation

Related Topics:
Continue Reading

Technology

Tessa AI Launches Tessa Newslink, a Free Tool That Checks Health News Against the Research Behind It

Published

3 seconds ago

on

October 21, 2026

By

Readers paste a link to a health story, and Newslink finds the studies behind it and shows, claim by claim, what the science actually supports

TUCSON, Ariz., Oct. 21, 2026 /PRNewswire/ — Tessa AI, Inc. (formerly Siensmetrica, Inc.) today launched Tessa Newslink, a free web tool that checks the health and medical claims in a news story against the published research behind them. Readers paste the link to an article into Newslink at news.tessapp.ai and, typically within one to four minutes, receive a plain-language report showing which of the story’s claims the research supports, which it overstates, and which it doesn’t address at all.

Health claims reach the public through news stories, podcasts, social media, influencers and product marketing, and many of them point to real studies. But as a finding travels from a journal to a headline to a social post, the details that determine what it means are often lost along the way: how many people were studied, whether the study involved people or mice, and whether it showed cause and effect or only a correlation. Few readers have the time or training to track down the original paper and check.

“Most people never get past the headline, but that isn’t a character flaw. The research is hard to find and even harder to read,” said Marc Toth, CEO of Tessa AI. “Newslink does that legwork. It finds the study, reads it, and shows whether the story got it right, with links so anyone can check our work. We’re not asking people to trust an AI. We’re showing them the evidence.”

How Tessa Newslink works

Identifies the claims. Newslink reads the article and pulls out its key health and medical claims, noting how strongly each one is made.Finds the research. It searches PubMed, Europe PMC and Crossref for the studies the story relies on. When an article doesn’t name its source, Newslink looks for published research that closely matches the subject.Compares the two. It weighs what each study actually found against what the story says.Delivers a verdict. The story as a whole is rated Supported, Mostly Supported, Mostly Unsupported or Entirely Unsupported, with a green, yellow or red indicator that shows at a glance how well it holds up. Each claim is rated individually as Supported, Overstated, Unsupported, or Can’t Be Checked when the research doesn’t address it.

Every report links back to the original article, to each claim, to the research itself, and to Tessa’s Summary Analysis of each study, including its TScore, Tessa’s 0-to-100 rating of a study’s overall trustworthiness. Reports can be quickly shared to X, LinkedIn or Facebook, or by link through email and text.

Newslink is designed for anyone who reads health news, including the people who report it. Journalists, editors, clinicians and patient advocates can use it to see what a study did and didn’t show before they cover it, cite it or pass it along.

“Health misinformation isn’t kept behind a paywall, so the tools for checking it shouldn’t be either,” Toth said. “Making Newslink free was the whole point.”

Newslink runs on the same T.E.S. (Transparency, Explainability, and Significance) analysis engine as Tessa and Tessa Pro, which researchers, clinicians, peer reviewers and biopharma professionals have used to evaluate biomedical research since the platform’s public launch in May 2026. Newslink evaluates whether published research supports the claims in a story; it does not provide medical advice.

Availability
Tessa Newslink is available now at no cost at https://news.tessapp.ai. There’s no account, sign-in or daily limit: readers simply paste in the link to the story they want to check.

Tessa AI is also exploring partnerships with health, news and social media platforms interested in bringing Newslink’s claim checking to their audiences. Publishers and platforms can reach the company at partners@tessaai.co.

Tessa AI’s product team will also preview Newslink this week with attendees of DOC 2026: Longevity Science & Medical AI in Sonoma, Calif.

About Tessa AI, Inc.
Tessa AI, Inc. (formerly Siensmetrica, Inc.) develops Tessa, an AI-powered platform that evaluates the trustworthiness of biomedical and healthcare research. Built on the T.E.S. (Transparency, Explainability, and Significance) framework, Tessa uses coordinated, specialized AI agents to assess a paper’s methodology, citations, reporting completeness, and risk of bias, and shows the evidence behind every score. The company’s products, including Tessa, Tessa Pro, and the free Tessa Newslink, support scientific research across its full lifecycle, from evaluating published studies to checking how they’re reported to the public. Learn more at www.tessaai.co.

Media contact:
Sage Osterfeld, CMO
425295@email4pr.com 
+1 (760) 593-7243

View original content:https://www.prnewswire.com/news-releases/tessa-ai-launches-tessa-newslink-a-free-tool-that-checks-health-news-against-the-research-behind-it-302915067.html

SOURCE Tessa AI, Inc.

Continue Reading

Technology

SKG Wins Three Global Travel Retail Awards, Showcasing Technology for Modern Travel and Expanding Global Presence

Published

6 seconds ago

on

October 21, 2026

By

PARIS, Oct. 21, 2026 /PRNewswire/ — Chinese health technology brand SKG has received three honors at the Global Travel Retail Awards 2026, with its G7 Pro Fold Neck Massager winning both “Best Technology Product” and “Best Travel Accessory,” while the W9 Ultra Waist Massager earned “Best Travel Exclusive Product.” Notably, “Best Technology Product” and “Best Travel Exclusive Product” were introduced for the first time in 2026, making SKG the inaugural winner in both categories. https://www.skg.com/?utm_source=media_name&utm_medium=pr&utm_campaign=product_launch_2026

The Global Travel Retail Awards is the only consumer-voted award in the global duty-free and travel retail industry. 80% of the final score comes from 5,000 international travelers selected from research agency m1nd-set’s traveler database, while a panel of travel content creators determines the remaining 20% following a three-day hands-on evaluation in London. This year’s winners also included internationally recognized brands such as Marc Jacobs and Clarins.

Under the awards program’s long-standing practice, both winning SKG products will enter global travel retail channels carrying the “Voted by Shoppers” designation, a mark that organizers say can significantly enhance consumer purchase intent.

Technology for Travel Wellness

The recognition comes as global air travel continues to recover and long-haul journeys, multi-stop itineraries, and intensive business travel become increasingly common. As travelers pay greater attention to managing neck, shoulder, and lower-back discomfort on the move, wearable wellness devices are becoming a regular part of carry-on essentials.

Designed to address these real-world travel needs, the G7 Pro Fold combines a 180-degree foldable structure with a lightweight 278-gram design, making it easy to pack and carry. The device integrates pulse stimulation, physical vibration, heat therapy, and dual-spectrum photothermal technology to provide a comprehensive relaxation experience during travel.

The award-winning W9 Ultra features multiple independently driven massage heads capable of simulating kneading, pinching, pressing, and other massage techniques across different body zones. Combining medium-frequency pulse technology with surround photothermal therapy, it features a flexible wearable design that can be comfortably used over clothing.

Behind these products is a long-term commitment to technology development and standards leadership. SKG has invested continuously in research and development for 19 years and holds more than 1,500 registered patents worldwide, including over 300 granted invention patents. The company operates a technology research institute, proprietary manufacturing facilities, and nine core laboratories. In China, it also led the development of the industry standard Household and Similar-Use Low-Frequency Massagers (QB/T 8100-2024), which took effect in July 2025.

Expanding Global Presence

The awards also reflect SKG’s broader globalization strategy. Rather than relying solely on an export-driven approach, the company has increasingly focused on building a localized presence in overseas markets. To address differences in wearing habits, ergonomic preferences, language environments, and service expectations, SKG extends localization efforts beyond distribution to product functionality, industrial design, user interfaces, regulatory compliance, and after-sales support. The company has established corporate or operational entities in China, Singapore, the United States, and the Netherlands, supported by an overseas team of nearly 100 employees.

Today, SKG products are available in more than 50 countries and regions across North America, Europe, Asia-Pacific, the Middle East, and Latin America. The brand sells through online platforms including Amazon, Lazada, Shopee, and its direct-to-consumer website, while also partnering with major offline retailers such as Costco, MediaMarkt, Saturn, Bic Camera, Takashimaya, and Selfridges. According to a Frost & Sullivan study completed in April 2025, SKG ranked No. 1 globally in smart massager sales revenue for three consecutive years from 2022 to 2024. Between 2023 and 2025, SKG achieved nearly twofold growth in revenue from markets outside mainland China.

As travel retail continues to evolve, SKG’s latest recognition highlights how technology-driven wellness products are responding to the realities of modern travel while demonstrating the company’s ongoing transition from exporting products to building lasting roots in global markets.

About SKG Health

Founded in 2007, SKG Health takes its name from the values “Smart, Kind and Global” and is a global leader in health technology focused on wearable devices across massage, sports recovery and everyday wellness. Its products are available in more than 50 countries and regions. Frost & Sullivan ranked SKG first in global smart massager sales from 2022 through 2024.

For more information, please visit https://www.skg.com/?utm_source=media_name&utm_medium=pr&utm_campaign=product_launch_2026.

View original content to download multimedia:https://www.prnewswire.com/news-releases/skg-wins-three-global-travel-retail-awards-showcasing-technology-for-modern-travel-and-expanding-global-presence-302915472.html

SOURCE SKG

Continue Reading

Technology

Real-time Hiring Data Offers Universities a New Way to Connect Students with Career Opportunities

Published

15 seconds ago

on

October 21, 2026

By

Rollie Jobs reduces administrative burden for career services teams while expanding access to timely, relevant job postings

SOUTH BEND, Ind., Oct. 21, 2026 /PRNewswire/ — Helping students connect their education to meaningful career opportunities is a top priority for colleges and universities. As institutions continue to invest in student career success, new technologies are helping streamline connections between students and employers while creating efficiencies that support campus career services teams.

Rollie Jobs is expanding its work within higher education, bringing its AI-powered workforce intelligence platform to universities seeking to expand career opportunities for students, help career services teams work more efficiently and strengthen relationships with employer partners.

Rather than relying on employers to manually submit job postings, Rollie automatically aggregates active postings from employers and industries of interest to create continuously updated, branded job boards. The result is a simpler, more effective experience for everyone involved: career services teams spend less time managing listings and more time supporting students; students discover a broader, more current range of jobs; and employers benefit from greater exposure to qualified candidates.

“Students and families increasingly expect a college degree to open doors to meaningful careers,” said Alex Sejdinaj, co-founder of Rollie Jobs. “Career services teams play a critical role in helping students navigate their futures, and technology should make that work easier, not more complicated. Rollie automatically surfaces job opportunities from employers without requiring manual uploads or another account for students to access listings. That means institutions can complement existing career services efforts, strengthen connections with employers and help more students discover meaningful opportunities.”

Connecting Education and Employment
Rollie is currently working with higher education partners, including the University of Notre Dame, to explore new ways of connecting students with employment opportunities while giving career services teams and university leaders greater visibility into employer hiring activity.

Notre Dame’s Mendoza College of Business recently implemented Rollie’s technology in its graduate business career services stack, supporting staff efficiency while surfacing targeted opportunities from employers in specific fields.

“As employer recruiting continues to evolve, we have to be equally thoughtful and innovative in how we connect students with opportunities,” said Christina Frank-Lieberg, director of external engagement for the Mendoza College of Business. “Preparing students for lives of purpose includes helping them discover meaningful career opportunities. Rollie helps us deepen relationships with employers while giving students access to timely, relevant opportunities that support informed career decisions.”

Beyond the Job Board
Higher education institutions have access to more workforce information than ever before, from graduate outcomes and employer feedback to industry advisory boards and labor market reports. Rollie complements those resources by providing a continuously updated view of employer demand, helping institutions turn workforce data into actionable intelligence.

“AI has the potential to make workforce intelligence dramatically more accessible,” said Chris Frederick, co-founder of Rollie Jobs. “Instead of spending hours gathering information from multiple sources, university leaders can ask questions, explore hiring trends and gain meaningful insights in minutes. Our goal is to help institutions spend less time searching for information and more time building stronger connections between students, employers and opportunity.”

As higher education continues to focus on student career outcomes, Rollie helps institutions connect students with more career opportunities by automatically discovering job postings, eliminating manual job board management and giving students access to a continuously updated view of what employers are hiring for right now.

To learn more or schedule a demonstration, visit www.rolliejobs.com.

About Rollie Jobs
Rollie Jobs is an AI-powered workforce intelligence platform that helps organizations automatically collect live job postings, explore workforce data using AI and publish branded job boards. Serving chambers of commerce, economic development organizations, workforce partners and higher education institutions, Rollie transforms employer hiring activity into actionable workforce intelligence that helps organizations connect talent with opportunity. Visit www.rolliejobs.com.

Media Contact:

Ann Hastings
For Rollie Jobs
574-210-8425
425107@email4pr.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/real-time-hiring-data-offers-universities-a-new-way-to-connect-students-with-career-opportunities-302915000.html

SOURCE Rollie Jobs

Continue Reading

Trending